PHILADELPHIA — More than eight months ago, large studies found that both the Pfizer-BioNTech and Moderna COVID-19 vaccines reduced the risk of illness by more than 90%. Yet the U.S. Food and Drug Administration has not yet granted them full approval, to the dismay of public-health officials eager to boost vaccination rates as the delta variant sends infections skyward. So what’s the holdup? ... Read more

It’s been a little more than a month since the N.H. Department of Health and Human Services released COVID-19 vaccination rates by town. Although local municipalities requested town-level rate… Read more

A voluntary recall has been issued for one of Price Chopper’s brands of coleslaw and several prepared seafood items due to the potential presence of plastic and metal fragments in the products… Read more

Some people may be hesitant to be vaccinated for COVID-19 because they think the vaccines were developed too quickly. But today’s successes are the result of many years of coronavirus research. Read more

The excuses range from the merely false to the absurd. The shots don’t work. They impair fertility. They’ll alter your DNA. They’ll magnetize you. They actually spread the virus. Unvaccinated Americans cite a litany of myths to explain their hesitance to get shots, confounding local health officials battling yet another surge of coronavirus cases fueled by the more transmissible delta variant. ... Read more

A new laboratory study suggests recipients of Johnson & Johnson’s coronavirus vaccine may need a second dose. Experts say: We’re not sure yet. The study, which was posted by bioRxiv on Tuesday, found J&J’s vaccine to be less effective against the delta and lambda variants compared with the original virus. It suggests that a second dose, ideally of Pfizer or Moderna, might help increase ... Read more

  • Updated

At least 118 deaths this year have been attributed to drug overdoses in New Hampshire, with another 96 possible drug deaths awaiting the results of toxicology testing, according to data releas… Read more

At 15, Autumn Fuernisen is dying. She was diagnosed at age 11 with a rare degenerative brain disorder that has no known cure or way to slow it down: juvenile-onset Huntington’s disease. “There’s lots of things that she used to be able to do just fine,” said her mom, Londen Tabor, who lives with her daughter in Gillette, Wyoming. Autumn’s speech has become slurred and her cognitive skills ... Read more

WASHINGTON — Deaths from drug overdoses soared to more than 93,000 last year, a staggering record that reflects the coronavirus pandemic’s toll on efforts to quell the crisis and the continued… Read more

Dr. Anthony Fauci said Tuesday that health experts don’t have enough data yet to determine whether and when to recommend extra protection for those who have already been vaccinated. “We’re not there yet,” Fauci told Andrea Mitchell on MSNBC. “They’ll be examining data as it comes in.” Fauci, who has become a lightning rod for right-wing anti-vaxxers, said the decision about recommending ... Read more

The head of the U.S. Food and Drug Administration said she is seeking a federal investigation of the approval of the Biogen Inc. Alzheimer’s disease drug Aduhelm, a highly unusual step that wi… Read more

Scientists who sifted through the genetic data of nearly 50,000 COVID-19 patients have discovered 13 key locations among the human genome's 3 billion base pairs that may influence a person's susceptibility to a coronavirus infection or their risk of developing a severe illness. The findings, published Thursday in the journal Nature, could help researchers design or repurpose treatments for ... Read more

For many people, the hot summer days are often spent swimming at the pool. But even though the water is usually clear with chlorine, it doesn’t mean you should be looking underwater. Read more

  • Updated

Cedarcrest Center for Children with Disabilities has appointed a new leader, after announcing in January its longtime president and CEO is retiring. Read more

NEW YORK — Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine, based on early data showing that it can sharply increase immune protection against the coronavirus. The company has received initial data from an early human study showing that a third dose of its existing coronavirus vaccine is safe and can raise neutralizing ... Read more